Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday. IONS has been the subject of a number of other reports. Needham & Company LLC reaffirmed a “buy” rating and set a […]
Ionis Pharmaceuticals, Inc (NASDAQ:IONS) EVP Patrick R O neil Sells 6,450 Shares themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $49 07 Consensus Target Price from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, four have given a hold rating, seven have given a buy rating and one […]
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday. A number of other equities research analysts have also recently commented on the company. Royal Bank of Canada reissued an outperform rating and issued a $65.00 price objective […]